RANBAXY LABORATORIES LTD.

RANBAXY LABORATORIES LTD. - Updates

	< Back
07 Apr 2014
Ranbaxy Laboratories Ltd has informed BSE that United States Attorney's Office for the District of New Jersey has issued an administrative subpoena dated March 13, 2014 to Ranbaxy seeking information primarily related to the Company's API Toansa manufacturing facility in India for which a Form 483 was issued by FDA culminating into import alert. The Toansa facility is subject to certain terms of Consent Decree entered against Ranbaxy in January 2012. The Company is fully cooperating with this information request. Ranbaxy is confident that its pharmaceutical products are safe and effective and is committed in its efforts to remain fully compliant with the US Regulatory standards.
View all announcements for RANBAXY LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us